Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
Rapid Micro Biosystems (Nasdaq: RPID) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company, which specializes in providing mission critical automation solutions for healthcare product manufacturing, will deliver its presentation on Thursday, January 16, 2025, at 12:45 p.m. Eastern Time (9:45 a.m. Pacific Time).
Interested parties can access a live webcast of the presentation through the company's investor relations website at investors.rapidmicrobio.com. The presentation will also be archived and available for replay following the event.
Rapid Micro Biosystems (Nasdaq: RPID) ha annunciato la sua partecipazione al 43° Annual J.P. Morgan Healthcare Conference. L'azienda, specializzata nella fornitura di soluzioni di automazione critiche per la produzione di prodotti sanitari, presenterà il suo intervento giovedì 16 gennaio 2025, alle 12:45 ora orientale (9:45 ora pacifica).
Le parti interessate possono accedere a un webcast dal vivo della presentazione tramite il sito web delle relazioni con gli investitori dell'azienda su investors.rapidmicrobio.com. La presentazione sarà anche archiviata e disponibile per la riproduzione dopo l'evento.
Rapid Micro Biosystems (Nasdaq: RPID) ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan. La empresa, que se especializa en proporcionar soluciones de automatización críticas para la fabricación de productos de salud, realizará su presentación el jueves 16 de enero de 2025, a las 12:45 p.m. hora del este (9:45 a.m. hora del pacífico).
Las partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de relaciones con inversores de la empresa en investors.rapidmicrobio.com. La presentación también será archivada y estará disponible para reproducir después del evento.
Rapid Micro Biosystems (Nasdaq: RPID)는 제43회 J.P. Morgan Healthcare Conference에 참가한다고 발표했습니다. 의료 제품 제조를 위한 필수 자동화 솔루션을 제공하는 전문 회사인 이 회사는 2025년 1월 16일 목요일 미국 동부 시간으로 오후 12:45 (태평양 시간으로 오전 9:45)에 발표를 진행할 예정입니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트인 investors.rapidmicrobio.com을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표는 또한 아카이브되어 이벤트 후에 다시 시청할 수 있습니다.
Rapid Micro Biosystems (Nasdaq: RPID) a annoncé sa participation à la 43e Conférence Annuelle de Santé J.P. Morgan. L'entreprise, spécialisée dans la fourniture de solutions d'automatisation essentielles pour la fabrication de produits de santé, présentera son intervention le jeudi 16 janvier 2025, à 12h45 heure de l'Est (9h45 heure du Pacifique).
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site Internet de relations avec les investisseurs de l'entreprise à l'adresse investors.rapidmicrobio.com. La présentation sera également archivée et disponible en replay après l'événement.
Rapid Micro Biosystems (Nasdaq: RPID) hat seine Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz angekündigt. Das Unternehmen, das sich auf die Bereitstellung kritischer Automatisierungslösungen für die Herstellung von Gesundheitsprodukten spezialisiert hat, wird seine Präsentation am Donnerstag, den 16. Januar 2025, um 12:45 Uhr Eastern Time (9:45 Uhr Pacific Time) halten.
Interessierte Parteien können über die Investor-Relations-Website des Unternehmens unter investors.rapidmicrobio.com auf einen Live-Webcast der Präsentation zugreifen. Die Präsentation wird auch archiviert und nach der Veranstaltung für eine Wiederholung verfügbar sein.
- None.
- None.
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference.
The Company is scheduled to present on Thursday, January 16, 2025, at 12:45 p.m. Eastern Time (9:45 a.m. Pacific Time). A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.
FAQ
When is RPID presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch RPID's J.P. Morgan Healthcare Conference presentation?
What is the focus of Rapid Micro Biosystems' (RPID) business?
Which annual healthcare conference is RPID participating in for 2025?
